Abstract The epicutaneous histamine (EH) test is the current gold standard method for the clinical evaluation of allergic conditions. However, the EH method is limited in providing an objective and qualitative assessment of histamine pharmacodynamic response. The histamine iontophoresis with laser Doppler (HILD) monitoring method, an alternative method, allows a fixed dose of histamine to be delivered and provides an objective, continuous, and dynamic measurement of histamine epicutaneous response in children and adults. However, due to the high sampling frequency (up to 40 Hz), the output files are usually too cumbersome to be directly used for further analysis. In this study, we developed an averaging algorithm that efficiently reduces the HILD data in size. The reduced data was further analyzed and a population linked effect pharmacokinetic/pharmacodynamic (PK/PD) model was developed to describe the local histamine response. The model consisted of a onecompartment PK model and a direct-response fractional maximum effect (Emax) model. The parameter estimates were obtained as follows: absorption rate constant (ka), 0.094/min; absorption lag time (Tlag), 2.72 min; partitioning clearance from local depot to systemic circulation (CLpar), 0.0006 L/min; baseline effect (E0), 13.1 flux unit; Emax, 13.4; concentration at half maximum effect (EC50) 31.1 mg/L. Covariate analysis indicated that age and race had significant influence on Tlag and EC50, respectively.
Introduction
The epicutaneous histamine (EH) test is the current gold standard method for the clinical evaluation of allergic conditions (e.g. allergic rhinitis) [1] . EH testing assesses the microvasculature response to histamine through the observation and measurement of the 'wheal and flare' response which results from vasodilatation and vascular leakage after activation of histamine receptors. EH testing is also utilized in clinical trials to assess antihistamine efficacy and duration of effect [1, 2] . However, the EH method is limited in providing an objective and quantitative assessment of histamine pharmacodynamic response. Limitations include operator subjectivity and inter-operator variability; discontinuous measurements; and variable histamine dosing.
We have shown that the Histamine iontophoresis with laser Doppler (HILD) monitoring method allows a fixed dose of histamine to be delivered and provides an objective, continuous, and dynamic measurement of histamine epicutaneous response in children and adults [3, 4] . Characterization of histamine response in patients with allergic disease may be important in defining disease phenotypes whereby therapeutic treatment with antihistamines may be more beneficial. Among children with allergic rhinitis, we have identified distinct histamine response phenotypes via the HILD method [3] . These response phenotypes may be important in future pharmacological studies of antihistamines in children and adults with allergic disease.
As mentioned one of the advantages of HILD over EH method is that the former allows continuous histamine measurements over time. However, it has also been a challenge to expand the use of its output results. Due to the high sampling frequency (up to 40 Hz), the output files are usually too cumbersome to be directly used for further analysis. This has limited the analysis of HILD results for broader clinical implications. In addition, no attempts have been made to assess the HILD measured endpoints from an advanced pharmacometric angle. In this study, we developed an averaging algorithm that efficiently reduces the HILD data in size. The reduced data was further analyzed and described using a population linked effect pharmacokinetic/pharmacodynamic (PK/PD) model.
Methods Subjects
All study participants were enrolled in an IRB-approved protocol after obtaining parental permission and, when appropriate (i.e. age C 7), child assent. Convenience sampling was utilized for this study. Children with a diagnosis of asthma were enrolled from allergy, asthma and immunology outpatient clinics at The Children's Mercy Hospital in Kansas City, MO. Asthma was defined by C12 % post-bronchodilator reversibility in forced expiratory volume in 1 s (FEV1) or by an Allergy/Asthma specialist diagnosis based on clinical symptoms in children unable to perform spirometry. Exclusion criteria included: (1) history of immunodeficiency, mastocytosis, chronic abnormal conditions of the skin, liver or kidney, neoplastic disease, or movement or neurologic disorders; (2) active eczema on the forearms at the time of study; (3) history of a previous anaphylactic episode; and (4) evidence of pregnancy (by urinary human chorionic gonadotropin) or lactation at the time of the study.
HILD method
HILD was performed in 169 participants in an identical fashion. A detailed description of the HILD technique used was previously published [3] . Baseline blood flow was assessed and blood flow measurement (provided in units of flux) was continuously conducted after histamine administration. Blood flow measurements were obtained until return to baseline or for up to a maximum duration of 2 h.
Data processing
Data collected from HILD monitoring was re-sampled using an averaging algorithm. The raw individual data (up to 3600 data points per subject) was first evenly divided into 200 segments with each containing approximately 18 observations. Within each segment, every data point was examined for potential outliers based on interquartile range rule [5] . An averaged signal was calculated by taking the mean of signals within each segment. The corresponding time was assigned by taking the median time point within the segment. With this approach, each individual data set was reduced to 200 observations (averaged data). A final screening was conducted to select 10-15 data points per subject to further reduce the size (reduced data), while maintaining a realistic representation of the histamine response over time curve. Data from 13 patients were excluded due to data quality and integrity. The re-sampled data sets were then pooled together and subjected to pharmacometric modeling. An example of the individual data processing is shown in Fig. 1 . Software NONMEM v7.3 (ICON Dev. Soln., Ellicott City, MD) was used to build the population PK/PD model. First-order conditional estimation with eta-epsilon interaction method (FOCEI) was used to run the models. Pearl-speaks-NON-MEM (PsN) 4.4.0 and Pirana 2.9.0 were used to facilitate the model developing and conduct the bootstrap and visual predictive check (VPC) analysis. Goodness-of-fit plots were generated by running user-defined codes in RStudio (R version 3.2.1). Xpose4 package under R environment was used to plot the results of VPC.
PK/PD linked effect model
A PK/PD linked effect model was developed to describe the histamine response over time monitored by HILD. The model is composed of a one-compartment PK model and a direct-response fractional Emax PD model (Fig. 2a) . The PK model is characterized by one compartment, first-order elimination, and first-order absorption with a lag time. The PD model is a direct-response fractional Emax model with gamma fixed to 1. The model is expressed mathematically as below:
where A0 is the amount of histamine remaining to be absorbed; A1 is the amount of histamine in the local depot;
A2 is the amount of histamine in the central plasma compartment; V1 is the local volume of distribution; V2 is the central plasma volume of distribution; CLpar is the partitioning clearance from local depot to systemic circulation; CL is the central clearance; ka is the absorption rate constant; F is the fraction of histamine absorbed; E is the local response observed; E0, is the baseline effect; Emax is the maximum effect; EC50 is the histamine concentration at half of the maximum effect. Since F was not determined in the current model, the clearance and volume of distribution parameters were estimated with F adjustments (CLpar/F, CL/F and V1/F). A delay of absorption (Tlag) was also included in the software setting but not shown in the above equations. A0 was initialized to dosing amount after accounting for Tlag, while A1 and A2 were initialized to 0. Between-subject variability (BSV) was initially investigated for all PK and PD parameters assuming an exponential error model:
where P i is the individual parameter value for ith subject; h is the population mean of the parameter; g i is the individual variability from the population mean in the ith subject. Residual variability was separately assessed as additive error, proportional error and additive/proportional combined error model. The variability was best described with an additive error model:
where Obs i,j denotes the jth HILD measurement in the ith subject. E i,j is the model-predicted jth HILD read for the ith subject. e i,j is the residual error of the jth measurement in the ith subject.
Both g and e were assumed to be normally distributed with expectation of 0, and variance of x 2 and r 2 , respectively.
Patient age, weight, height, BMI, sex, race, ethnicity and diagnosis of asthma were evaluated for their potential effects upon histamine pharmacokinetic and pharmacodynamic parameters. A stepwise covariate search was performed based on improvement of OFV with forward selection (p = 0.05) and backward elimination (p = 0.01). Power relationship was assumed for continuous covariates (age, weight, height, BMI), and linear relationship was assumed for categorical covariate (sex, race, ethnicity, diagnosis of asthma):
where h* is covariate adjusted population mean of the parameter; h is the population mean of the parameter; Cov is the continuous covariate value; Median is the median of the continuous covariate values in the dataset; b co is the estimated power value for the corresponding continuous covariate; b ca is the estimated value assigned to each level of the categorical covariate. The final covariate model was used to describe the local histamine response in studied patients.
Results
The demographic information of patients is listed ( Table 1 ). The original data for each subject contained up to 3600 observations (measured at 40 Hz, sampled at 0.5 Hz) for up to 120 min. To reduce the data size to a suitable and manageable level for pharmacometric modeling, an averaging algorithm was applied to reduce the size to 15-20 observations per subject. The final data set contained a total of 2494 observations from 156 subjects. The histamine response by HILD monitoring was described by a PK/PD linked effect model (Fig. 2a) . The model is composed of a one-compartment PK model with first-order absorption, and a direct-response fractional Emax PD model. Different error models (additive, proportional, combined, etc.) were tested and additive error model was found to best describe the data.
BSV was investigated for all parameters and was retained for CLpar, E0 and Emax. The base model was reached with an OFV of 17402.4. All parameters were estimated with high confidence ( Table 2 ). The local volume of distribution (V1) was fixed to be 0.006 L to increase the model identifiability. No substantial eta-or epsilonshrinkage was observed for any random-effect parameters: g CL shrinkage = 3.8 %, g E0 shrinkage = 19.4 %, g EMAX shrinkage = 36.9 % and e shrinkage = 6.4 %. Goodnessof-fit plots demonstrated a good description of data by the model (Supplementary Fig. 1 ). Simulations of the residual histamine amount in absorption depot (A0) and local histamine concentration (A1/V1) are plotted (Fig. 2b) .
Stepwise covariate search returned age and race as significant covariates on Tlag and EC50, respectively ( Table 2 ). Goodness-of-fit plots demonstrated improved model fitting, especially for the population prediction, after including these covariate effects in the final model (Supplementary Fig. 2 ). Individual fitting plots are also included ( Supplementary Fig. 6 ). A bootstrap analysis with 500 simulations was conducted to assess the model stability and finished with 99.2 % success rate. The bootstrap mean and 95 % confidence intervals of the parameter estimates were in close agreement with the final model estimates (Table 2) . A VPC analysis was done and the result is (Fig. 3) , which demonstrates that the variability of the data was sufficiently explained by the model.
Discussion
The use of laser Doppler flowmetry for assessment of histamine response test has previously been described [6] . However, we have utilized HILD to both deliver a fixed dose of histamine and to provide a more robust measurement of response than has previously been reported. We have taken advantage of the very rich data obtained from the HILD method to more fully characterize the histamine response. Furthermore, we have developed an algorithm to reduce the data size to a suitable level for population pharmacometric modeling while still maintaining important characteristics that allows classification of differing response phenotypes. A population PK/PD linked effect model was developed and described the histamine response over time data with high confidence. While HILD method provides much more quantifiable measurements, the richly sampled data has been difficult to use for pharmacometric analysis due to several reasons. First, measurements may be redundant. The sampling frequency is very high (up to 40 Hz) and histamine response occurs over a prolonged period. Therefore, it is not necessary to take all the data points to build a sufficiently accurate model. Second, due to the high sampling frequency, individual data sets often reach over 3000 observations. Dealing with such a large data size is a major challenge for population modeling approaches using currently available software packages. Third, due to the intensive sampling and the measurement variability, sampled data are very noisy. Dramatic outliers caused by measurement disturbance (e.g. participant movement) are also recorded and will lead to biased parameter estimates if not detected and excluded. These have been the major challenges to utilizing HILD data for pharmacometric analysis purposes.
To overcome the challenges and, more importantly, to take advantage of the richness of data, we developed an averaging algorithm that reduces the data size while maintaining a realistic representation of the histamine response over time. The essence of the algorithm is to take the average of signals within relatively small time segments and at the same time scan for potential outlier data points. We divided each individual data set into 200 segments (about 20 seconds of measurement each). Considering the histamine response feature and sampling frequency, this number was chosen so that the signals within each segments were at comparable levels and therefore the averaging strategy was feasible. The averaged data set is characterized by a smooth response curve with much fewer data points. Following this step, an easy reduction step was conducted to select representative data points. With this treatment, the data redundancy was reduced and the data sets were brought to a manageable size for population modeling. During the segmentation step, a screening process for potential outliers was conducted simultaneously. The exclusion was based on the interquartile range rule [5] . Observations falling outside (Q1 -1.5 9 IQR, Q3 ? 1.5 9 IQR) range were identified as potential outliers and therefore excluded. Such a criterion was efficient in excluding outliers for two reasons. First, the histamine response is overall continuous in spite of measurement noise. Second, outliers usually deviate from true signals dramatically due to physical disturbance. The criterion was shown to successfully retain almost all true signals while excluding most potential outliers.
Although previous investigators have utilized the PD model to describe antihistamine effect [1, 2, 7, 8] , this study is the first to explore the feasibility of modeling histamine response measured by HILD method. HILD method has been used to monitor the histamine-induced local blood flow modification after antihistamine treatment [9, 10] . However, interpretation of such measurements has traditionally been simple and descriptive. Here we applied more advanced pharmacometric approaches to further analyze the results.
To our knowledge, this study is the first attempt to access local histamine response over time through a population modeling approach. A PK/PD linked effect model was developed. The choice of the model structure reflected the fact that the measured local response was a function of loading dose and time after dose [11] . In recognition of the Occam's razor principle [12] and due to the lack of systemic or local (at measurement site) histamine exposure data, the simplest 1-compartmental model structure was assumed and applied. Nonetheless, the current model structure still has a mechanistic presentation of the local histamine PK [13] . For the PD, a direct-response fractional Emax model was used to describe the response that is driven by local histamine concentrations. When evaluating candidate model structures, the structurally simpler direct response PD model was chosen over the indirect model in order to minimize the number of parameters to be estimated. Initial attempts of modeling the data using the indirect model structure (featuring kin and kout in addition to Emax and EC50) were unsuccessful (data not shown). Error messages and convergence failure indicated overparameterization. This was likely due to the fact that local histamine concentrations were not available in the current study design, and therefore the more complex indirect model structure could not be sufficiently supported by the data structure.
Due to the lack of plasma PK data in current study, we took a series of approaches in order to increase the model identifiability and to confirm the validity of the current model structure. First, the local volume of histamine distribution was assumed to have similar value as observed in the traditional 'wheal-and-flare' test. A typical 'flare' surface area lies around 22 cm 2 [2] . The three layers of dermal structures at forearm have typical thickness of 0.2 mm (epidermis), 1.2 mm (dermis) and 1.2 mm (hypodermis including subcutaneous fat) [14, 15] . A typical local volume of distribution can then be calculated as 22 cm 2 9 (0.2 ? 1.2 ? 1.2) mm = 0.0057 L. Therefore, a volume of 0.006 L was fixed in current model to reflect this physiology. Second, the partitioning clearance estimate was compared against corresponding parameter estimates from published study. Middleton et al. and Li et al. reported histamine plasma PK after subcutaneous injection [16, 17] . The published data were digitized, and fitted into a population model ( Supplementary Fig. 3A ) to estimate Table 1 ; Fig. 4 ). In this model, ka2 describes the rate of histamine partitioning from local subcutaneous depot to systemic circulation, and corresponds to CLpar/V1 in our local model (Fig. 2a) . Comparison of the values of ka2 estimate (0.095/min) with CLpar/V1 (0.1/min) revealed very close resemblance. This suggests that the partitioning process (from local histamine into circulation) described by our current model agrees well with published evidence. Third, a model linking local and plasma histamine concentrations was constructed and fitted for the digitized plasma PK data after local subcutaneous injections (Supplementary Fig. 3B ). The model was intended to demonstrate that assuming current local partitioning model structure, the corresponding plasma PK should mimic the published results. Therefore, in this model, V1 and CLpar were fixed to 0.006 L and 0.0006 L/min as in our local base model, while other parameters were estimated. The central PK parameter estimates agreed well with those from modeling digitized data (Table 3,  Supplementary Table 1 ). VPC analysis also showed that the predicted plasma PK profile overlay very well with published data (Fig. 4) . All these evidence have brought confidence to the current model in correctly describing the partitioning process of local histamine to circulation.
Covariate analysis revealed that Tlag was significantly associated with age, while EC50 was significantly associated with race. Example plots of key PD parameter values vs. Covariates and selected individual PD profiles are presented (Fig. 5, Supplementary Fig. 5 ). Early investigation of Laser Doppler flowmetry have revealed minimal differences related to age and race [18] . Presumed race related differences may instead be related to observed genetic variation in the histamine production, response, and degradation pathway [19] . The advanced model provides a much more precise way to describe the variability of histamine response in population and suggests broader application of HILD method in allergy pharmacodynamic research. BSV between-subject variability, 95 % CI 95 % confidence intervals, RSE % relative standard error percentage
Conclusion
The richly sampled HILD data was reduced to a suitable size for pharmacometric analysis using an averaging algorithm. The reduced data set was best described by a population PK/PD linked effect model. The model consists of a one-compartment PK model with first-order absorption, first-order elimination and an absorption lag time, and a direct-response fractional Emax model. This study has demonstrated the feasibility of modeling HILD data for pharmacodynamic purpose.
